comparemela.com

Latest Breaking News On - Baillie gifford co - Page 8 : comparemela.com

Insider Selling: Enphase Energy, Inc. (NASDAQ:ENPH) Director Sells 319,526 Shares of Stock

Enphase Energy, Inc. (NASDAQ:ENPH – Get Free Report) Director Thurman J. Rodgers sold 319,526 shares of the business’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $126.53, for a total transaction of $40,429,624.78. Following the completion of the sale, the director now directly owns 1,984,562 shares […]

United-states
Craig-hallum
Thurmanj-rodgers
Piper-sandler
Quarter-for-enphase-energy
News-ratings-for-enphase-energy-daily
Barclays
Enphase-energy-trading-down
Enphase-energy-inc
Enphase-energy
Securities-exchange-commission
Enphase-energy-company-profile

J. L. Bainbridge & Co. Inc. Invests $206,000 in Xylem Inc. (NYSE:XYL)

J. L. Bainbridge & Co. Inc. purchased a new stake in shares of Xylem Inc. (NYSE:XYL – Free Report) in the 4th quarter, Holdings Channel reports. The fund purchased 1,800 shares of the industrial products company’s stock, valued at approximately $206,000. Several other institutional investors and hedge funds have also modified their holdings of the […]

Canada
Robertw-baird
Neptune-benson
Stifel-nicolaus
Baillie-gifford-co
Invesco-ltd
Jl-bainbridge-co
Citigroup
Xylem-inc
Northern-trust-corp
Xylem-company-profile
Royal-bank

Elevance Health, Inc. (NYSE:ELV) Shares Bought by Axiom Investors LLC DE

Axiom Investors LLC DE raised its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 35.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 154,684 shares of the company’s stock after purchasing an additional 40,624 shares during the period. Axiom Investors LLC DE owned about 0.07% […]

Canada
United-states
Feliciaf-norwood
Sanders-capital
Elevance-health-inc
Elevance-health-price-performance
Cantor-fitzgerald
Elevance-health-company-profile
Norges-bank
Insider-activity-at-elevance-health
Elevance-health-announces-dividend

Cellectis (NASDAQ:CLLS) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Cellectis (NASDAQ:CLLS – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Cellectis Stock Performance NASDAQ CLLS opened at $2.71 on Wednesday. The stock has a 50-day simple moving average of $2.77 and a 200 day simple moving […]

Exchange-commission
Cellectis-company-profile
Baillie-gifford-co
Free-report
Get-free-report
Cellectis-daily

PDD (NASDAQ:PDD) Stock Price Up 1.9%

PDD Holdings Inc. (NASDAQ:PDD – Get Free Report)’s share price traded up 1.9% during trading on Thursday . The stock traded as high as $155.50 and last traded at $154.19. 4,020,070 shares traded hands during mid-day trading, a decline of 56% from the average session volume of 9,052,293 shares. The stock had previously closed at […]

Sanfordc-bernstein
Sc-us-ttgp
Norges-bank
Citigroup
Pdd-holdings-inc
Vanguard-group-inc
Goldman-sachs-group
Company-profile
Baillie-gifford-co
Jefferies-financial-group
Holdings-inc

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.